DelveInsight’s Cystinosis market report thoroughly explains the Cystinosis historical and forecasted epidemiology and the Cystinosis market trends in the 7MM.
Key Takeaways from the Cystinosis Market Report
Request for a sample to know more @ Cystinosis Market Outlook
Cystinosis Overview
Cystinosis is a disease caused by an abnormal accumulation of a specific amino acid known as cysteine. It is a rare but severe disease with long-term consequences that can affect many body parts. Cystinosis is classified into three types based on when symptoms first appear (known as onset): infantile (early-onset) cystinosis, late childhood or adolescent (late-onset) cystinosis, and adult cystinosis.
Cystinosis Epidemiology Segmentation
The Cystinosis report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:
Cystinosis Treatment Landscape
There is currently no cure for Cystinosis, and treatment is limited to a few approved therapies that provide symptomatic relief. In the United States, three therapies are currently approved, one for ocular cystinosis and the other two for nephropathic cystinosis. The approved Cystinosis therapies include Procysbi (cysteamine bitartrate), Cystagon (cysteamine bitartrate), Cystaran (cysteamine hydrochloride), and Cystadrops (cysteamine hydrochloride).
Cystinosis Market Outlook
The Cystinosis market size was found to be USD 167 million in the 7MM in 2020.
The Cystinosis market will increase due to the introduction of new therapies such as ELX-02, AVR-RD-04, and others during the forecast period (2021-30).
Get a detailed analysis of the market @ Cystinosis Market Analysis
Cystinosis Pipeline Therapies and Key Companies
ELX-02: Eloxx Pharmaceuticals
AVR-RD-04 (CTNS-RD-04): Avrobio
Table of Contents
1.
Key Insights
2.
Report Introduction
3.
Cystinosis Market Overview at a Glance
4.
Executive Summary of Cystinosis
5.
Key Events
6.
Disease Background and Overview
7.
Treatment and Management of Cystinosis
8.
Epidemiology and Patient Population
9.
Patient Journey
10.
Marketed Therapies
11.
Emerging Therapies
12.
Cystinosis: Seven Major Market Analysis
13.
KOL Views
14.
Market Drivers
15.
Market Barriers
16.
SWOT Analysis
17.
Unmet Needs
18.
Market Access and Reimbursement
19.
Appendix
20.
DelveInsight Capabilities
21.
Disclaimer
22.
About DelveInsight
Get in touch with our business executive for Healthcare Due Diligence Services
Related Reports
Nephropathic Cystinosis Market
DelveInsight’s “Nephropathic Cystinosis – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Nephropathic Cystinosis , historical and forecasted epidemiology as well as the Nephropathic Cystinosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Sandeep JoshiEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: www.delveinsight.com/